ArticleMaterials today. Bio2025
Multiplexed polypeptide-based hybrid bacterial clusters by tailoring the conjugation for synergistic treatment of infected wounds.
Article in Materials today. Bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Drug-resistant bacterial infections and excessive inflammation pose serious challenges to wound healing. Currently, biomaterial-assisted antibacterial therapies demonstrate excellent therapeutic potential by enriching antibacterial agents at the site of infection and combining the advantages of multiple therapeutic agents. Here, inspired by bacterial aggregation behaviors in living organisms that regulate host physiological activities, a biomimetic polypeptide-based hybrid bacterial cluster is reported for treatment of infected wounds (PTS-UGT). Specifically, hybrid bacteria (UGT) were first constructed by a method of stepwise biological self-assembly with Staphylococcus epidermidis (SE) bacterial surface growth of gold and silver particles (UG) and polyphenolization of gold and silver particles. Subsequently, under the inducement of borate-diphenol coordination interactions and multiple hydrogen bonding, UGT was assembled with the side-chain boronic-acid-modified antibacterial polypeptide tobramycin (PTS) to form biomimetic hybrid bacterial clusters (PTS-UGT) by tailoring the conjugation methods. These clusters integrate the multiplexing and aggregation enhancement functions of bio-self-assembled gold, silver, polyphenol particles, bacterial immunomodulatory components and antibacterial polypeptides, which can effectively regulate the polarization of macrophages to M2 type and enhance the local effective drug concentration for multifunctional bacterial killing, thereby showing excellent antibacterial, anti-inflammatory and healing effects on infected wounds in mice, providing new ideas for the development of biomaterial-assisted antibacterial therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.